Source: Annual Congress 2002 - Pulmonary surfactant in the pathogenesis and treatment of acute respiratory failure
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
O. A. Rosenberg, A. E. Bautin, V. V. Osovskich, A. A. Seiliev, V. A. Volchkov, D. A. Granov (St-Peterburg, Russia). Surfactant therapy for ALI. Dose-effect relationship. Eur Respir J 2002; 20: Suppl. 38, 2337

Member's Comments

No comment yet.

Related content which might interest you: Surfactant therapy for post-bypass lung injury Source: Eur Respir J 2002; 20: Suppl. 38, 35s Year: 2002 Surfactant proteins in elastase-induced emphysema – change after ATRA treatment? Source: Eur Respir J 2007; 30: Suppl. 51, 59s Year: 2007 Surfactant therapy for acute lung injury and other lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 210s Year: 2003 Translocation of TNF-α from the gut to the lung by VILI is reduced by exogenous surfactant therapy Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002 Fluid therapy in ARDS Source: International Congress 2014 – Acute respiratory distress syndrome (ARDS): the role of prevention Year: 2014 The effects of simvastatin in ventilator-induced lung injury Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Relationship between CF lung structure and aerosol therapy Source: Annual Congress 2013 –PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults Year: 2013 When to start surfactant therapy (ST-therapy) of acute lung injury? Source: Eur Respir J 2001; 18: Suppl. 33, 7s Year: 2001 The association between LASSBio596 and surfactant improves lung morpho-function and reduces the inflammatory process in experimental sepsis-induced acute lung injury Source: Annual Congress 2010 - Acute respiratory failure Year: 2010 Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury Source: Eur Respir J 2009; 33: 634-645 Year: 2009 Surfactant in ARDS: does initial oxygenation improvement matter? Source: Annual Congress 2004 - The fourth ERS - free paper symposium on interdisciplinary basic and clinical surfactant research Year: 2004 Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Therapeutic lavage with rSP-C surfactant restores oxygenation and improves histological outcome in a rat lung lavage model of acute lung injury Source: Eur Respir J 2001; 18: Suppl. 33, 7s Year: 2001 Mechanisms responsible for surfactant changes in sepsis-induced lung injury Source: Eur Respir J 2005; 26: 1074-1079 Year: 2005 Promising effect of PMX-DHP absorption therapy for acute exacerbation of IPF Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Surfactant pretreatment preserves lung function in ischemia-reperfusion-injury of the lung Source: Eur Respir J 2005; 26: Suppl. 49, 221s Year: 2005 Correlation of surfactant changes and pulmonary functions in the mechanically ventilated patients with ARDS Source: Eur Respir J 2002; 20: Suppl. 38, 470s Year: 2002 Effects of therapy by low-dose surfactant enriched with dextran in newborn rabbits with acute lung injury Source: Annual Congress 2004 - The fourth ERS - free paper symposium on interdisciplinary basic and clinical surfactant research Year: 2004 Novel method of whole lung lavage therapy using biphasic cuirass ventilator for pulmonary alveolar proteinosis; the retrospective observational study. Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020